2025年6月20日至23日,第85届美国糖尿病协会科学会议(ADA)在芝加哥McCormick会展中心举行。作为全球糖尿病领域最高规格的学术舞台,本届会议汇集了礼来、诺和诺德、信达生物、甘李药业等数十家药企,披露了超过200项临床研究。从GLP-1多靶点升级到胰岛素周制剂,从口服减重药到胰淀素疗法,一场关乎千亿美元代谢疾病市场的技术竞赛正在加速。01巨头的“武器库”:礼来的全管线碾压此次会议不乏...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.